We are live on ! Find out more
AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
1-Year Est. Return 58.35%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
-58.35%
3 Year Est. Return
-89.8%
5 Year Est. Return
-87.69%
10 Year Est. Return
–
AUM
$57.4M
AUM Growth
-$3.36M
Cap. Flow
-$4.71M
Cap. Flow %
-8.21%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CBLK
Carbon Black, Inc. Common Stock
CBLK
+$4.71M

Sector Composition

Rank Sector Weight
1 Healthcare 95.73%
2 Communication Services 4.27%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTLA icon
1
Intellia Therapeutics
NTLA
$1.5B
$23.7M 41.29%
1,615,321
– –
SPRO icon
2
Spero Therapeutics
SPRO
$68.9M
$13.2M 23.08%
1,376,968
– –
SURF
3
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$8.73M 15.22%
4,645,453
– –
SYBX
4
DELISTED
Synlogic
SYBX
$6.84M 11.92%
176,798
– –
SNAP icon
5
Snap
SNAP
$8.29B
$2.45M 4.27%
150,160
– –
COGT icon
6
Cogent Biosciences
COGT
$6.69B
$2.42M 4.22%
840,384
– –
CBLK
7
DELISTED
Carbon Black, Inc. Common Stock
CBLK
– –
-181,273
Closed -$4.71M

Similar funds

EEPIS
Evolution Equity Partners II SARL Luxembourg $11.8M AUM 63.6% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
MM
Malka Meyer $8.77M AUM 64.77% 1-Year Est. Return

Atlas Venture Associates IX's Q4 2019 Portfolio in Review

As of Q4 2019, Atlas Venture Associates IX held 7 positions worth $57.4M, down 5.5% from $60.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Associates IX withdrew a net $4.71M in Q4 2019, closing 1 position. Its most notable exit was Carbon Black, Inc. Common Stock, an estimated $4.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 88% a quarter earlier, followed by Communication Services and Technology.

  • Atlas Venture Associates IX fully exited Carbon Black, Inc. Common Stock in Q4 2019, selling an estimated $4.71M.
  • Atlas Venture Associates IX's ten largest holdings make up 100% of its $57.4M portfolio in Q4 2019.
  • Atlas Venture Associates IX opened 0 new positions and closed 1 in Q4 2019.
  • Atlas Venture Associates IX's portfolio value fell 5.5% quarter-over-quarter to $57.4M.

Based on Atlas Venture Associates IX's 13F filing for Q4 2019, filed 11 Feb 2020.